Detalhe da pesquisa
1.
IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms.
Blood
; 140(26): 2805-2817, 2022 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36283106
2.
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
Blood
; 139(19): 2931-2941, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007321
3.
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Blood
; 134(18): 1498-1509, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515250
4.
Validation of simple prediction algorithms to consistently achieve CD3+ and postselection CD34+ targets with leukapheresis.
Transfusion
; 60(1): 133-143, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756000
5.
Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study.
Biol Blood Marrow Transplant
; 25(2): 256-264, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30205231
6.
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis.
Biol Blood Marrow Transplant
; 25(6): 1142-1151, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30625392
7.
Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells.
Blood
; 126(8): 972-82, 2015 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26022238
8.
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis.
Blood
; 124(7): 1183-91, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24963042
9.
Mysterious clumping in a cell therapy product.
Transfusion
; 61(8): 2232-2233, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273121
10.
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells.
Cancer Res Commun
; 3(5): 943-951, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377894
11.
Insights into highly engraftable hematopoietic cells from 27-year cryopreserved umbilical cord blood.
Cell Rep Med
; 4(11): 101259, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37913777
12.
A Phase Ib Trial of AVID200, a TGFß 1/3 Trap, in Patients with Myelofibrosis.
Clin Cancer Res
; 29(18): 3622-3632, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439808
13.
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses.
Cell Host Microbe
; 31(1): 97-111.e12, 2023 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36347257
14.
Stem Cell Educator therapy in type 1 diabetes: From the bench to clinical trials.
Autoimmun Rev
; 21(5): 103058, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108619
15.
Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm-blast phase.
JCI Insight
; 7(8)2022 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35259128
16.
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease.
Front Immunol
; 13: 1055497, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36569951
17.
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms.
Nat Commun
; 13(1): 1750, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365653
18.
Broadly neutralizing antibodies target the coronavirus fusion peptide.
bioRxiv
; 2022 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35441178
19.
Broadly neutralizing antibodies target the coronavirus fusion peptide.
Science
; 377(6607): 728-735, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857439
20.
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants.
bioRxiv
; 2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821267